An Updated Systematic Review on Spinal Muscular Atrophy Patients Treated with Nusinersen, Onasemnogene Abeparvovec (at Least 24 Months), Risdiplam (at Least 12 Months) or Combination Therapies.
European Journal of Paediatric Neurology（2024）
关键词
Spinal muscular atrophy,Nusinersen,Onasemnogene abeparvovec,Risdiplam
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要